People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PACEpartners Inc. | — | Biotechnology | Series A | $9.0M | $326.7M | 2013 |
| Vivione Biosciences Inc. | — | Biotechnology | Pre-Seed | $216K | $11.9M | 2014 |
Ian E. Gallie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ian E. Gallie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James K. Hendren | 1 | 4 |
| KEVIN D. KUYKENDALL | 1 | 2 |
| Chester J. Jachimiec | 1 | 2 |
| Kevin Kuykendall | 1 | 1 |
| Phillip A. Tuttle | 1 | 1 |
| Glenn K. Smith | 1 | 1 |
| C. Lal Narang | 1 | 1 |
| Philip A. Tuttle | 1 | 1 |
| Ted D. Moskal | 1 | 1 |
| Ted J. Moskal | 1 | 1 |
| C. Lai Narang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.